Archives

Use the basic search or click on advanced for more search options.

Advanced Search Basic Search Advanced Search

Publications

Section

Select publication to see the relevant sections.

Publication Date

    E.g., 2018-10-20
    E.g., 2018-10-20

Archive Search

Pages

216 results
12:56 PM, Sep 22, 2017  |  BC Week In Review | Financial News  |  Other Financial News

Lightstone closes $250M fund

lipid disorders company Catabasis Pharmaceuticals Inc. (NASDAQ:CATB), neurological diseases company Flex Pharma Inc. (NASDAQ:FLKS) and peptide therapeutics
11:35 AM, Jul 06, 2017  |  BC Week In Review | Financial News  |  Completed Offerings

Novo Seeds invests €2.7M in Antag

Seeds, the early stage investment arm of Novo Holdings A/S (Hellerup, Denmark). Antag is developing peptide therapeutics
8:14 PM, Jun 08, 2017  |  BC Week In Review | Financial News  |  Proposed Offerings

Aileron proposes $69M IPO

On June 2, stapled peptide therapeutics company Aileron Therapeutics Inc. (Cambridge, Mass.) proposed to raise $69 million …
12:54 PM, Feb 17, 2017  |  BC Week In Review | Financial News  |  Completed Offerings

Rhythm Holding completes venture financing

Venture Investments, Third Rock Ventures and an undisclosed public healthcare investment fund. The company develops peptide therapeutics
12:00 AM, Sep 12, 2016  |  BC Week In Review | Company News  |  Deals

PeptiDream, Tokyo Institute of Technology deal

PeptiDream and the institute partnered to discover and develop in silico constrained peptide therapeutics. The partners will …
12:00 AM, Nov 02, 2015  |  BC Week In Review | Company News  |  Deals

Cloud Pharmaceuticals, Therametrics deal

Cloud and Therametrics partnered to discover, develop and commercialize small molecule and peptide therapeutics for Orphan central …
12:00 AM, Oct 19, 2015  |  BC Week In Review | Company News  |  Deals

PeptiDream, Sanofi deal

The companies partnered to generate macrocyclic and constrained peptide therapeutics against multiple undisclosed targets selected by the …
12:00 AM, May 18, 2015  |  BC Week In Review | Company News  |  Deals

PeptiDream, Merck deal

PeptiDream partnered with Merck to generate macrocyclic and constrained peptide therapeutics against multiple undisclosed targets from the …
12:00 AM, Sep 02, 2013  |  BC Week In Review | Company News  |  Deals

Zealand Pharma, Eli Lilly deal

Zealand partnered with Eli Lilly to discover and develop peptide therapeutics to treat Type II diabetes and …
12:00 AM, Apr 15, 2013  |  BC Week In Review | Company News  |  Deals

Peptide Therapeutics, Medeva deal

million (US$5 million) for 882,353 newly issued ordinary shares of PTE for £3.40 per share. Peptide Therapeutics

Pages